Immunoassay for the specific detection of hydrocodone
A new immunoassay for the specific detection of hydrocodone has received 510 (k) clearance from the U.S. Food and Drug Administration (FDA). The DRI Hydrocodone Assay is a homogeneous enzyme immunoassay featuring requisite sensitivities that meet the newly proposed Substance Abuse and Mental Health Administration (SAMHSA) guidelines using a 300 ng/mL cut-off. SAMHSA oversees the […]
